Latest News

Joseph Swedish has more than two decades senior experience in US-based healthcare organisations, including most recently as executive chairman, president and CEO of health benefits provider Anthem.

Medical diagnostics pioneer Rhythm Biosciences (ASX:RHY) has announced that the key next phase of reagent development has been completed successfully and ahead of schedule.

Australian stem cell and regenerative medicine company Cynata Therapeutics (ASX:CYP) has announced positive safety and efficacy data from a 28 day analysis of patients in Cohort B of its Phase 1 clinical trial of CYP-001.

Australia may have avoided making a detailed commitment on extending the data protection period for biologics in the Trans-Pacific Partnership Agreement but the issue will almost certainly be part of negotiations for a new free trade agreement with the European Union.

Australian cancer company Sirtex (ASX:SRX) has announced it has accepted a $1.9 billion takeover bid from Chinese company CDH Genetech Limited.

Regenerative medicine company Orthocell (ASX:OCC) has announced the presentation of updated positive results from a study of its tendon cell therapy treatment for tennis elbow in 24 patients who suffered work-related injuries and disability.

New leadership for MSD Australia and New Zealand with the departure of Riad El-Dada for another position in the company's global organisation.

Sydney headquartered clinical research organisation Novotech has signed a Memorandum of Understanding (MOU) with the China Medical University Hospital (CMUH) in Taiwan.

Gilead has welcomed recognition for its chief scientific officer and head of R&D in the 2018 Queen's Birthday Honours.

Regenerative tissue developer, Upside Biotechnologies, has raised NZ$2 million in a convertible note offer to progress the commercialisation of its technology.

AusBiotech has welcomed the appointment of Liz de Somer as the new chief executive of Medicines Australia.

Bayer has completed its US$66 billion acquisition of the world's largest seeds and crop chemicals company, Monsanto.